Items related to Drugs and a Methodological Compendium: From bench to...

Drugs and a Methodological Compendium: From bench to bedside - Hardcover

 
9789811979514: Drugs and a Methodological Compendium: From bench to bedside

Synopsis

This book provides a meticulous view on methodological drug discovery insights from bench to bedside. The current book mainly focuses on basic drug targeting principles, highlighting the paramount significance of each step during the course of fixing the target to the discovery and delivery of the drug molecule. The chapters focus on target identification approaches, modern high-throughput screening methods, computational modus operandi, pharmacological optimization, role of structural biologists in drug discovery and development,  medicinal chemistry approaches for drug design, formulation and drug delivery, in-vivo evaluations of candidate molecules, clinical trial procedures and others. The book also encompass the specific case studies, regulatory approval proceedings, and industrial view point alongside the aforementioned conceptual layout. And at the same time, the volume integrates medical, biological, medicinal, pharmacological and computational streams, and it is suggested as an ideal guideline to a wide audience including molecular biologists, biochemist, pharmacologists, medicinal chemist, toxicologists, drug discovery and development researchers, and all other students interested in these disciplines.

"synopsis" may belong to another edition of this title.

About the Author

Vikrant Singh Rajput graduated with B. Tech in Biotechnology (2010) from Amity University, Noida, UP, India, a Ph.D in Biological Science from CSIR-Indian Institute of Integrative Medicine, Jammu, J&K, India (2017). He was awardedpostdoctoral fellowship from Indian Institute of Technology (IIT) Roorkee and Young Scientist Award/Research grant from Department of Health Research (Govt. of India). He has also held different positions like Adhoc Faculty at National Institute of Technology (NIT) Raipur andProject scientist at Biosafety Support Unit, Regional Centre for Biotechnology, Faridabad. He currently works as Scientist at Foundation For Neglected Diseases Research, Bengaluru, India working on TB and other bacterial pathogens drug discovery.

Areas of interest:TB biology; TB and anti-bacterial drug discovery; Combatting drug resistance; Novel drug targets; Computational drug discovery and immunoinformatics.

 

Ashish Runthala graduated with M.Sc. in Biological Science (2005) from BITS Pilani, Rajasthan, India. Meanwhile qualifying the National Eligibility test (NET), he pursued the M.E. in Biotechnology (2008) here and completed Ph.D in Computational Biology in 2016. He was awarded the Ucchayatar Avishkar Yojana (UAY) in 2017 from Indian Institute of Science. Starting his academic responsibilities at BITS Pilani from 2005, he has held several positions viz. Teaching Assistant, Assistant Lecturer, Lecturer and Visiting Faculty. He has also worked at Presidency University Bangalore as an Assistant Professor. He is currently working as an Associate Professor at KL University, Vijayawada, and is doing research on developing the functionally improved enzymes of the DXP pathway for enhancing the overall yield of the pathway.

Areas of interest: Computational algorithms; Bioinformatics; Protein structure prediction; Enzyme design; Decoding active site; Designing thermostable enzyme.


From the Back Cover

This book provides a meticulous view on methodological drug discovery insights from bench to bedside. The current book mainly focuses on basic drug targeting principles, highlighting the paramount significance of each step during the course of fixing the target to the discovery and delivery of the drug molecule. The chapters focus on target identification approaches, modern high-throughput screening methods, computational modus operandi, pharmacological optimization, role of structural biologists in drug discovery and development,  medicinal chemistry approaches for drug design, formulation and drug delivery, in-vivo evaluations of candidate molecules, clinical trial procedures and others. The book also encompass the specific case studies, regulatory approval proceedings, and industrial view point alongside the aforementioned conceptual layout. And at the same time, the volume integrates medical, biological, medicinal, pharmacological and computational streams, and it is suggested as an ideal guideline to a wide audience including molecular biologists, biochemist, pharmacologists, medicinal chemist, toxicologists, drug discovery and development researchers, and all other students interested in these disciplines.

"About this title" may belong to another edition of this title.